LncRNAs specifically overexpressed in endocervical adenocarcinoma are associated with an unfavorable recurrence prognosis and the immune response

View article
Bioinformatics and Genomics

Main article text

 

Introduction

Materials and Methods

Raw data

Definitions of clinical survival and recurrence types

LncRNA score, tumor purity and immune score

Identification of target genes and enrichment analysis

Analyses of populations and subpopulations of infiltrating immune cells

RT-qPCR

Statistical analysis

Results

LincRNAs and antisense RNAs specifically expressed in EAC rather than other types of LncRNAs

EAC LncRNAs were differentially expressed in EAC and CSCC

EAC LncRNAs were significantly overexpressed in EAC but not CSCC

Overexpression of LncRNAs specifically expressed in EAC was associated with an unfavorable recurrence prognosis

LncRNAs specifically expressed in EAC are involved in the immune response and cancer-related pathway

EAC-specific LncRNA overexpression inhibits immune responses in the cervical cancer microenvironment, particularly in EAC

Discussion

Conclusions

Supplemental Information

Analysis of lncRNA’s target based on ENCORI dataset.

(A) Barplot showing the number of dysregulated cancer types of each target genes from ENCORI dataset. (B) Network of lncRNAs and their target gene from ENCORI dataset. (C) Barplot showing the—logP of enrichment signature based on these target gene from ENCORI dataset.

DOI: 10.7717/peerj.12116/supp-2

The correlations between lncRNAs and Bcell, CD4 T cell and CD8 T cell.

(A–B) Dot plots showing the correlations between lncRNAs (A: lincRNAs and B: antisense RNA) and B cell, CD4 T cell and CD8 T cell from TIMER. (C–D) Dot plots showing the correlations between lncRNAs (C: lincRNAs and D: antisense RNA) and B cell, CD4 T cell and CD8 T cell from EPIC. (E–F) Dot plots showing the correlations between lncRNAs (E: lincRNAs and F: antisense RNA) and B cell, CD4 T cell and CD8 T cell from CIBERSORT.

DOI: 10.7717/peerj.12116/supp-3

Infiltrating Immune Cells related genes.

DOI: 10.7717/peerj.12116/supp-4

The names of the LncRNAs and antisense RNAs.

DOI: 10.7717/peerj.12116/supp-5

Clinical case information of patients.

DOI: 10.7717/peerj.12116/supp-6

Additional Information and Declarations

Competing Interests

The authors declare that they have no competing interests.

Author Contributions

Yong Song conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, and approved the final draft.

Long Nie conceived and designed the experiments, performed the experiments, prepared figures and/or tables, and approved the final draft.

Yu-ting Zhang analyzed the data, authored or reviewed drafts of the paper, and approved the final draft.

Human Ethics

The following information was supplied relating to ethical approvals (i.e., approving body and any reference numbers):

The medical ethics committee of Suizhou Hospital, Hubei University of Medicine approved this research.

Data Availability

The following information was supplied regarding data availability:

The raw measurements are available in the Supplemental File.

Funding

The authors received no funding for this work.

1 Citation 1,335 Views 184 Downloads

Your institution may have Open Access funds available for qualifying authors. See if you qualify

Publish for free

Comment on Articles or Preprints and we'll waive your author fee
Learn more

Five new journals in Chemistry

Free to publish • Peer-reviewed • From PeerJ
Find out more